Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
35.07
-1.86 (-5.04%)
At close: Aug 20, 2025, 3:59 PM
35.42
1.00%
After-hours: Aug 20, 2025, 07:43 PM EDT

Caris Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
100.83M 85.69M 80.8M
Cost of Revenue
46.74M 42.83M 42.21M
Gross Profit
54.09M 42.87M 38.59M
Operating Income
66.44M 50.84M 48.76M
Interest Income
n/a n/a n/a
Pretax Income
54.83M 39.8M 37.18M
Net Income
51.16M 37.94M 35.74M
Selling & General & Admin
12.29M 10.17M 7.74M
Research & Development
n/a n/a n/a
Other Expenses
n/a n/a n/a
Operating Expenses
12.29M 10.17M 7.74M
Interest Expense
n/a 11.11M 11.17M
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
59.03M 53M 49.95M
Income Tax Expense
3.68M 1.86M 2.5M
Shares Outstanding (Basic)
17.34M 17.28M 17.27M
Shares Outstanding (Diluted)
17.53M 17.48M 17.52M
EPS (Basic)
2.95 2.20 2.07
EPS (Diluted)
2.92 2.17 2.04
EBITDA
87.72M 80.39M 78.18M
EBIT
n/a 50.91M 48.35M
Depreciation & Amortization
32.88M 29.48M 28.77M